NuVascular Technologies, Inc. has recently obtained exclusive licensing rights to commercialize a breakthrough medical device that will provide a minimally invasive treatment for heart disease , the No. 1 cause of death in the United States accounting for one in every four deaths.
http://ift.tt/1yEmLNu
http://ift.tt/1yEmLNu
No comments:
Post a Comment